Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Healthcare & Medical Investment Corporation (3455)
Market Open
12 Aug, 06:00
JPX
All
(1)
JP
(1)
JPX
Primary
¥
104,100.
00
-700
-0.6679%
¥
42.89B
Market Cap
-
P/E Ratio
6,572%
Div Yield
38
Volume
-
Eps
¥
104,800
Previous Close
Watching
Watch
Add Transaction
Day Range
104,000
104,800
Year Range
102,600
131,800
Want to track
3455
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Statistics
Historical Data
Healthcare & Medical Investment Corporation (3455) Statistics
Valuation metrics
Market Cap
42.89B
Enterprise value
64.36B
Trailing P/E (ttm)
18.68
Forward P/E
-
PEG ratio
-
Price/Sales (ttm)
7.48
Price/Book (mrq)
1.02
Enterprise Value/Revenue
12.42
Enterprise Value/EBITDA
16.71
Overview
Shares outstanding
359.5K
Float
307.54K
Shares short
-
% Held by insiders
0.08%
% Held by institutions
0.4%
Average volume (10 days)
1.19K
Average volume (90 days)
1.18K
Price summary
52-Week low
102,600
52-Week high
131,800
Beta
0.18
50-Day moving average
114,916
200-Day moving average
118,646.5
Dividends and splits
Forward annual dividend rate
6,572
Forward annual dividend yield
0.0612%
Trailing annual dividend rate
6,450
Trailing annual dividend yield
0.0601%
5-Year annual dividend yield
4.79%
Payout ratio
1.12
Dividend Date
5 Feb 2026
Ex-Dividend Date
29 Jan 2026
Last split factor
-
Last split Date
-
Financials
Fiscal year
Fiscal year ends
31 Jan 2026
Most recent quarter (mrq)
31 Jan 2026
Profitability
Profit margin
0.4%
Operating margin
0.52%
Operational effectiveness
Return on assets
0.02%
Return on equity
0.05%
Income Statement
Revenue (ttm)
5.18B
Revenue per share (ttm)
14,414.82
Quarterly revenue growth (yoy)
0.04%
Gross profit (ttm)
2.81B
EBITDA
3.85B
Net income to common (ttm)
2.07B
Diluted EPS (ttm)
5,771.84
Quarterly earnings growth (yoy)
0.03%
Balance Sheet
Total cash (mrq)
1.79B
Total cash per share (mrq)
5,762.04
Total debt (mrq)
33.15B
Total Debt/Equity (mrq)
100.45
Current ratio (mrq)
0.36%
Book value per share (mrq)
106,112.2
Cash Flow
Cash flow statement
3.42B
Levered free cash flow (LFCF)
2.53B